{"url_path":"/sec/coya/proxy/2026-05-13/000119312526220690","section_key":"body","section_title":"DEFA14A body","topic":"sec","document":{"doc_type":"DEFA14A","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1835022/0001193125-26-220690-index.html","accession_number":"0001193125-26-220690","cik":"0001835022","ticker":"COYA","issuer_name":"Coya Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1835022/0001193125-26-220690-index.html","primary_entity_key":"0001835022","primary_entity_name":"Coya Therapeutics, Inc."},"word_count":779,"has_tables":true,"body_markdown":"DEFA14A\n1\nd78974ddefa14a.htm\nDEFA14A\n\nDEFA14A\n\n**United States**\n\n**Securities and Exchange Commission**\n\n**Washington, D.C. 20549**\n\n**SCHEDULE 14A**\n\n**Proxy\nStatement Pursuant to Section 14(a) of the**\n\n**Securities Exchange Act of 1934**\n\nFiled by the Registrant ☒\n\nFiled by a Party other\nthan the Registrant ☐\n\nCheck the appropriate box:\n\n☐\n\nPreliminary Proxy Statement\n\n☐\n\nConfidential, for Use of the Commission Only (as permitted by Rule\n14a-6(e)(2))\n\n☐\n\nDefinitive Proxy Statement\n\n☒\n\nDefinitive Additional Materials\n\n☐\n\nSoliciting Material under §240.14a-12\n\n**COYA THERAPEUTICS, INC.**\n\n**(Name of Registrant as Specified in its Charter)**\n\n**(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)**\n\nPayment of Filing Fee (Check all boxes that apply):\n\n☒\n\nNo fee required\n\n☐\n\nFee paid previously with preliminary materials\n\n☐\n\nFee computed on table in exhibit required by Item 25(b) per Exchange Act Rules\n14a-6(i)(1) and 0-11\n\nMMMMMMMMMMMM C 1234567890 ENDORSEMENT_LINE______________ SACKPACK_____________ MMMMMMM MR A SAMPLE Online DESIGNATION (IF ANY) ADD 1 Go\nto www.envisionreports.com/COYA or scan 000001 ADD 2 the QR code — login details are located in the ADD 3 ADD 4 shaded bar below. MMMMMMMMM ADD 5 ADD 6 Votes submitted electronically must be received by 11:59 p.m., E.T., on June 24, 2026.\n2026 Stockholder Meeting Notice 1234 5678 9012 345 Important Notice Regarding the Availability of Proxy Materials for the Coya Therapeutics, Inc. Stockholder Meeting to be Held on June 25, 2026. Under Securities and Exchange Commission rules,\nyou are receiving this notice that the proxy materials for the annual stockholders’ meeting are available on the Internet. Follow the instructions below to view the materials and vote online or request a copy. The items to be voted on and\nlocation of the annual meeting are on the reverse side. Your vote is important! This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of\nthe important information contained in the proxy materials before voting. The 2026 Proxy Statement; Annual Report on Form 10-K for the Year Ended December 31, 2025 are available at:\nwww.envisionreports.com/COYA Easy Online Access — View your proxy materials and vote. Step 1: Go to www.envisionreports.com/COYA. Step 2: Click on Cast Your Vote or Request Materials. Step 3: Follow the instructions on the screen to log in.\nStep 4: Make your selections as instructed on each screen for your delivery preferences. Step 5: Vote your shares. When you go online, you can also help the environment by consenting to receive electronic delivery of future materials. Obtaining a\nCopy of the Proxy Materials – If you want to receive a copy of the proxy materials, you must request one. There is no charge to you for requesting a copy. Please make your request as instructed on the reverse side on or before June 15,\n2026 to facilitate timely delivery. 2 NOT COY 04AGRA\n\n2026 Stockholder Meeting Notice The 2026 Annual Meeting of Coya Therapeutics, Inc. will be held on June 25, 2026 at 12:00 p.m.\nC.T., virtually via the Internet at meetnow.global/MJTM52T Proposals to be voted on at the meeting are listed below along with the Board of Directors’ recommendations. The Board of Directors recommend a vote FOR all the nominees listed and FOR\nProposal 2: 1. Election of Directors: 01—Wilbur Ross 02—Dieter Weinand 2. To ratify the appointment of Weaver and Tidwell, L.L.P. as our independent registered public accounting firm for the year ending December 31, 2026\nPLEASE NOTE – YOU CANNOT VOTE BY RETURNING THIS NOTICE. To vote your shares you must go online or request a paper copy of the proxy materials to receive a proxy card. If you wish to attend and vote at the meeting, please bring this notice with\nyou. Here’s how to order a copy of the proxy materials and select delivery preferences: Current and future delivery requests can be submitted using the options below. If you request an email copy, you will receive an email with a link to the\ncurrent meeting materials. PLEASE NOTE: You must use the number in the shaded bar on the reverse side when requesting a copy of the proxy materials. — Internet – Go to www.envisionreports.com/COYA. Click Cast Your Vote or Request\nMaterials. — Phone – Call us free of charge at 1-866-641-4276. — Email – Send an email to\ninvestorvote@computershare.com with “Proxy Materials Coya Therapeutics, Inc.” in the subject line. Include your full name and address, plus the number located in the shaded bar on the reverse side, and state that you want a paper copy of\nthe meeting materials. To facilitate timely delivery, all requests for a paper copy of proxy materials must be received by June 15, 2026."}